Discuss This Drug

selexipag

CHEBI:CHEBI_90844

Definition

A member of the class of pyrazines that is N-(methanesulfonyl)-2-{4-[(propan-2-yl)(pyrazin-2-yl)amino]butoxy}acetamide carrying two additional phenyl substituents at positions 5 and 6 on the pyrazine ring. An orphan drug used for the treatment of pulmonary arterial hypertension. It is a prodrug for ACT-333679 (the free carboxylic acid).

Chemical Information

Molecular Formula
C26H32N4O4S
Molecular Mass
496.624
Charge
0
SMILES
C1(=C(N=CC(=N1)N(CCCCOCC(NS(C)(=O)=O)=O)C(C)C)C2=CC=CC=C2)C3=CC=CC=C3
InChI
InChI=1S/C26H32N4O4S/c1-20(2)30(16-10-11-17-34-19-24(31)29-35(3,32)33)23-18-27-25(21-12-6-4-7-13-21)26(28-23)22-14-8-5-9-15-22/h4-9,12-15,18,20H,10-11,16-17,19H2,1-3H3,(H,29,31)
InChIKey
QXWZQTURMXZVHJ-UHFFFAOYSA-N

Alternative Names

  • 2-{4-[(5,6-diphenylpyrazin-2-yl)(propan-2-yl)amino]butoxy}-N-(methanesulfonyl)acetamide
  • ACT 293987
  • ACT-293987
  • NS 304
  • NS-304
  • selexipag
  • Uptravi

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

DRON_00010000
1729002
oboInOwl#hasDbXref
Wikipedia:Selexipag
core#notation
CHEBI:90844

Additional References

Wikipedia:Selexipag

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

oboInOwl#hasOBONamespace
chebi_ontology
DRON_00010000
1729002
oboInOwl#hasDbXref
Wikipedia:Selexipag
oboInOwl#id
CHEBI:90844
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT
listing_expiration_date
20241231
route
INTRAVENOUS
dosage_form
INJECTION, POWDER, FOR SOLUTION
marketing_start_date
20151221
labeler_name
Actelion Pharmaceuticals US, Inc.
generic_name
Selexipag (Form-I)
product_ndc
66215-608
spl_id
f29cd991-7d7d-514c-e053-2995a90a8de0
package_ndc
66215-608-06
package_description
1 BOTTLE in 1 CARTON (66215-608-06) / 60 TABLET, COATED in 1 BOTTLE
brand_name
UPTRAVI
brand_name_base
UPTRAVI
application_number
NDA214275
RO_0000087
http://purl.obolibrary.org/obo/CHEBI_50266
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#3_STAR
chebi#has_functional_parent
http://purl.obolibrary.org/obo/CHEBI_90848
core#notation
CHEBI:90844
rxcui
2565275
active_ingredient_strength
1800 ug/10mL
package_marketing_start_date
06-MAR-19
active_ingredient_name
SELEXIPAG
manufacturer_name
Actelion Pharmaceuticals US, Inc.
unii
5EXC0E384L
spl_set_id
a7a23b87-f892-4e2c-8e2e-ebf841220f90
nui
N0000020068
pharm_class_epc
Prostacyclin Receptor Agonist [EPC]
pharm_class
Prostacyclin Receptor Agonists [MoA]
pharm_class_moa
Prostacyclin Receptor Agonists [MoA]
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
has_treatment
http://purl.obolibrary.org/obo/DOID_6432
rdf-schema#domain
https://w3id.org/def/predibionto#has_side_effect38051
owl#annotatedSource
t317802
owl#someValuesFrom
t3798474